These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8875667)

  • 1. Tardive dyskinesia associated with fluoxetine.
    Dubovsky SL; Thomas M
    Psychiatr Serv; 1996 Sep; 47(9):991-3. PubMed ID: 8875667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choreiform dyskinesia with acute onset and protracted course following fluoxetine treatment.
    Nielsen AS; Mors O
    J Clin Psychiatry; 1999 Dec; 60(12):868-9. PubMed ID: 10665637
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine dose-increment related akathisia in depression: implications for clinical care, recognition and management of selective serotonin reuptake inhibitor-induced akathisia.
    Hansen L
    J Psychopharmacol; 2003 Dec; 17(4):451-2. PubMed ID: 14870959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
    Fava M; Judge R; Hoog SL; Nilsson ME; Koke SC
    J Clin Psychiatry; 2000 Nov; 61(11):863-7. PubMed ID: 11105740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Movement disorders associated with the serotonin selective reuptake inhibitors.
    Leo RJ
    J Clin Psychiatry; 1996 Oct; 57(10):449-54. PubMed ID: 8909330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxetine and tardive dyskinesia.
    Botsaris SD; Sypek JM
    J Clin Psychopharmacol; 1996 Jun; 16(3):258-9. PubMed ID: 8784663
    [No Abstract]   [Full Text] [Related]  

  • 8. Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
    Zarate CA; Kando JC; Tohen M; Weiss MK; Cole JO
    J Clin Psychiatry; 1996 Feb; 57(2):67-71. PubMed ID: 8591971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of complex movement disorder induced by fluoxetine with management of dystonia by botulinum toxin type A.
    Chen JJ; Swope DM
    J Clin Psychiatry; 2005 Feb; 66(2):267-8. PubMed ID: 15705018
    [No Abstract]   [Full Text] [Related]  

  • 11. Are patients who are intolerant to one SSRI intolerant to another?
    Brown WA; Harrison W
    Psychopharmacol Bull; 1992; 28(3):253-6. PubMed ID: 1480728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine and suicidal ideation.
    Ratan DA
    J Clin Psychopharmacol; 1997 Feb; 17(1):61-2. PubMed ID: 9004066
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluoxetine: new indication. Depression in children: too many uncertainties.
    Prescrire Int; 2008 Oct; 17(97):186-7. PubMed ID: 19534039
    [No Abstract]   [Full Text] [Related]  

  • 14. Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: a fluorine MRS study.
    Henry ME; Moore CM; Kaufman MJ; Michelson D; Schmidt ME; Stoddard E; Vuckevic AJ; Berreira PJ; Cohen BM; Renshaw PF
    Am J Psychiatry; 2000 Sep; 157(9):1506-8. PubMed ID: 10964871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to fluoxetine.
    Rapport DJ; Calabrese JR
    J Clin Psychopharmacol; 1993 Oct; 13(5):361. PubMed ID: 8227494
    [No Abstract]   [Full Text] [Related]  

  • 16. Sertraline-induced Hemichorea.
    Gatto EM; Aldinio V; Parisi V; Persi G; Da Prat G; Bullrich MB; Sanchez P; Rojas G
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():518. PubMed ID: 29276648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.
    Judge R; Parry MG; Quail D; Jacobson JG
    Int Clin Psychopharmacol; 2002 Sep; 17(5):217-25. PubMed ID: 12177584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral dyskinesia induced by fluoxetine therapy for infantile autism.
    Albertini G; Majolini L; Di Gennaro G; Quarato P; Scoppetta C; Onorati P; Albertini G; Majolini L; Di Gennaro G; Quarato P; Scoppetta C; Onorati P; Albertini G; Majolini L; Di Gennaro G; Quarato P; Scoppetta C; Onorati P
    Pediatr Neurol; 2004 Jul; 31(1):76. PubMed ID: 15246500
    [No Abstract]   [Full Text] [Related]  

  • 19. Itch and skin rash from chocolate during fluoxetine and sertraline treatment: case report.
    Cederberg J; Knight S; Svenson S; Melhus H
    BMC Psychiatry; 2004 Nov; 4():36. PubMed ID: 15522120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects of long-term treatment with fluoxetine.
    Buchman N; Strous RD; Baruch Y
    Clin Neuropharmacol; 2002; 25(1):55-7. PubMed ID: 11852298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.